MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Palma, Catalina A ^a,c   Al Sheikha, Dima ^a   Lim, Teck K ^a   Bryant, Adam ^a   Vu, Thi T ^a   Jayaswal, Vivek ^b   Ma, David D F ^a,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Acute Myeloid Leukaemia (AML); Apoptosis; microRNA; miR 155; Myeloid differentiation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARABINOSIDE; CASPASE 3; CD11B ANTIGEN; CD135 ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; COLECALCIFEROL; CTNNB1 PROTEIN; CYTARABINE; CYTARABINE ARABINOSIDE; GF1 PROTEIN; HEME OXYGENASE 1; JARID2 PROTEIN; LIPOCORTIN 5; LOCKED NUCLEIC ACID; MEIS1 PROTEIN; MICRORNA 155; MYC PROTEIN; PROCASPASE 3; PROTEIN; PROTEIN BCL X; PROTEIN C JUN; PROTEIN FOS; PROTEIN P53; SERINE PROTEINASE OMI; TRIB2 PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIMETABOLITE; FLT3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MICRORNA; MIRN155 MICRORNA, HUMAN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; BONE MARROW CELL; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MYELOID LEUKEMIA; UPREGULATION; ACUTE GRANULOCYTIC LEUKEMIA; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HL 60 CELL LINE; METABOLISM; MORTALITY; MUTATION; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL; TUMOR CELL CULTURE;

ANTIGENS, CD; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CASPASE 3; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTARABINE; EPIGENESIS, GENETIC; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICRORNAS; MUTATION; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 84899896641     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-79     Document Type: Article

References (66)

1. Palma CA, Tonna EJ, Ma DF, Lutherborrow MA. MicroRNA control of myelopoiesis and the differentiation block in acute myeloid leukaemia. J Cell Mol Med 2012, 16:978-987. 10.1111/j.1582-4934.2011.01514.x, 22225649.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
3. Dickstein J, Senyuk V, Premanand K, Laricchia-Robbio L, Xu P, Cattaneo F, Fazzina R, Nucifora G. Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. Proc Natl Acad Sci U S A 2010, 107:9783-9788. 10.1073/pnas.1004297107, 2906858, 20448201.
4. Guo S, Lu J, Schlanger R, Zhang H, Wang JY, Fox MC, Purton LE, Fleming HH, Cobb B, Merkenschlager M, Golub TR, Scadden DT. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci U S A 2010, 107:14229-14234. 10.1073/pnas.0913574107, 2922532, 20616003.
5. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD, Camargo FD. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129. 10.1038/nature06607, 18278031.
6. Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Muller-Tidow C, Bohlander SK, Tenen DG, Behre G. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778. 10.1182/blood-2009-08-240101, 2832809, 20029046.
7. He L, He X, Lim LP, De Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134. 10.1038/nature05939, 17554337.
8. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloofield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009, 113:6411-6418. 10.1182/blood-2008-07-170589, 2710934, 19211935.
9. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 2005, 102:3627-3632. 10.1073/pnas.0500613102, 552785, 15738415.
10. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007, 104:1604-1609. 10.1073/pnas.0610731104, 1780072, 17242365.
11. Sandhu SK, Volinia S, Costinean S, Galasso M, Neinast R, Santhanam R, Parthun MR, Perrotti D, Marcucci G, Garzon R, Croce CM. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Emu-miR-155 transgenic mouse model. Proc Natl Acad Sci U S A 2012, 109:20047-20052. 10.1073/pnas.1213764109, 3523868, 23169640.
12. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, Van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611. 10.1126/science.1139253, 2610435, 17463290.
13. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608. 10.1126/science.1141229, 17463289.
14. Tili E, Croce CM, Michaille JJ. miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 2009, 28:264-284. 10.1080/08830180903093796, 19811312.
15. Kluiver J, Poppema S, De Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005, 207:243-249. 10.1002/path.1825, 16041695.
16. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbro T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353:1793-1801. 10.1056/NEJMoa050995, 16251535.
17. Faraoni I, Laterza S, Ardiri D, Ciardi C, Fazi F, Lo-Coco F. MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status. J Hematol Oncol 2012, 5:26. 10.1186/1756-8722-5-26, 3416574, 22681934.
18. Kluiver J, Haralambieva E, De Jong D, Blokzijl T, Jacobs S, Kroesen BJ, Poppema S, van den Berg A. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 2006, 45:147-153. 10.1002/gcc.20273, 16235244.
19. Rokah OH, Granot G, Ovcharenko A, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Shpilberg O. Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PLoS One 2012, 7:e35501. 10.1371/journal.pone.0035501, 3325224, 22511990.
20. Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJM, Löwenberg B. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008, 111:5078-5085. 10.1182/blood-2008-01-133355, 18337557.
21. Cammarata G, Augugliaro L, Salemi D, Agueli C, La Rosa M, Dagnino L, Civiletto G, Messana F, Marfia A, Bica MG, Cascio L, Floridia PM, Mineo AM, Russo M, Fabbiano F, Santoro A. Differential expression of specific microRNA and their targets in acute myeloid leukemia. Am J Hematol 2010, 85:331-339.
22. Wang Y, Zhang X, Li H, Yu J, Ren X. The role of miRNA-29 family in cancer. Eur J Cell Biol 2013, 92:123-128. 10.1016/j.ejcb.2012.11.004, 23357522.
23. Xiang J, Wu J. Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis. Curr Genomics 2010, 11:129-135. 10.2174/138920210790886853, 2874222, 20885820.
24. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008, 205:585-594. 10.1084/jem.20072108, 2275382, 18299402.
25. Georgantas RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A 2007, 104:2750-2755. 10.1073/pnas.0610983104, 1796783, 17293455.
26. Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, De Hoon MJ, Kubosaki A, Kaiho A, Suzuki M, Yasuda J, Kawai J, Hayashizaki Y, Hume DA, Suzuki H. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 2010, 24:460-466. 10.1038/leu.2009.246, 19956200.
27. Lutherborrow M, Bryant A, Jayaswal V, Agapiou D, Palma C, Yang YH, Ma DD. Expression profiling of cytogenetically normal acute myeloid leukemia identifies microRNAs that target genes involved in monocytic differentiation. Am J Hematol 2011, 86:2-11. 10.1002/ajh.21864, 20981674.
28. Quentmeier H, Reinhardt J, Zaborski M, Drexler HG. FLT3 mutations in acute myeloid leukemia cell lines. Leukemia 2003, 17:120-124. 10.1038/sj.leu.2402740, 12529668.
29. Manz MG, Miyamoto T, Akashi K, Weissman IL. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A 2002, 99:11872-11877. 10.1073/pnas.172384399, 129361, 12193648.
30. Majeti R, Park CY, Weissman IL. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 2007, 1:635-645. 10.1016/j.stem.2007.10.001, 2292126, 18371405.
31. Bryant A, Palma CA, Jayaswal V, Yang YW, Lutherborrow M, Ma DDF. miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death. Mol Cancer 2012, 11:8. 10.1186/1476-4598-11-8, 3306826, 22348345.
32. Song J, Liu P, Yang Z, Li L, Su H, Lu N, Peng Z. MiR-155 negatively regulates c-Jun expression at the post-transcriptional level in human dermal fibroblasts in vitro: implications in UVA irradiation-induced photoaging. Cell Physiol Biochem 2012, 29:331-340. 10.1159/000338488, 22508041.
33. Dunand-Sauthier I, Santiago-Raber ML, Capponi L, Vejnar CE, Schaad O, Irla M, Seguin-Estevez Q, Descombes P, Zdobnov EM, Acha-Orbea H, Reith W. Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood 2011, 117:4490-4500. 10.1182/blood-2010-09-308064, 21385848.
34. Marcucci G, Maharry KS, Metzeler KH, Volinia S, Wu YZ, Mrozek K, Nicolet D, Kohlschmidt J, Whitman SP, Mendler JH, Schwind S, Becker H, Eisfeld AK, Carroll AJ, Powell BL, Kolitz JE, Garzon R, Caligiuri MA, Stone RM, Bloomfield CD. Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients. J Clin Oncol 2013, 31:2086-2093. 10.1200/JCO.2012.45.6228, 23650424.
35. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 2008, 105:3945-3950. 10.1073/pnas.0800135105, 2268779, 18308931.
36. Charrad RS, Li Y, Delpech B, Balitrand N, Clay D, Jasmin C, Chomienne C, Smadja-Joffe F. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med 1999, 5:669-676. 10.1038/9518, 10371506.
37. Chen A, Luo M, Yuan G, Yu J, Deng T, Zhang L, Zhou Y, Mitchelson K, Cheng J. Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells. Biotechnol Lett 2008, 30:2045-2052. 10.1007/s10529-008-9800-8, 18648749.
38. Lu C, Huang X, Zhang X, Roensch K, Cao Q, Nakayama KI, Blazar BR, Zeng Y, Zhou X. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011, 117:4293-4303. 10.1182/blood-2010-12-322503, 3087479, 21355095.
39. Ghani S, Riemke P, Schonheit J, Lenze D, Stumm J, Hoogenkamp M, Lagendijk A, Heinz S, Bonifer C, Bakkers J, Abdelilah-Seyfried S, Hummel M, Rosenbauer F. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood 2011, 118:2275-2284. 10.1182/blood-2011-02-335141, 21730352.
40. Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene 2007, 26:6816-6828. 10.1038/sj.onc.1210764, 17934488.
41. Dasse E, Volpe G, Walton DS, Wilson N, Del Pozzo W, O'Neill LP, Slany RK, Frampton J, Dumon S. Distinct regulation of c-myb gene expression by HoxA9, Meis1 and Pbx proteins in normal hematopoietic progenitors and transformed myeloid cells. Blood Cancer J 2012, 2:e76. 10.1038/bcj.2012.20, 3389162, 22829978.
42. Huang Y, Sitwala K, Bronstein J, Sanders D, Dandekar M, Collins C, Robertson G, MacDonald J, Cezard T, Bilenky M, Thiessen N, Zhao Y, Zeng T, Hirst M, Hero A, Jones S, Hess JL. Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood 2012, 119:388-398. 10.1182/blood-2011-03-341081, 3257007, 22072553.
43. Keeshan K, He Y, Wouters BJ, Shestova O, Xu L, Sai H, Rodriguez CG, Maillard I, Tobias JW, Valk P, Carroll M, Aster JC, Delwel R, Pear WS. Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. Cancer Cell 2006, 10:401-411. 10.1016/j.ccr.2006.09.012, 2839500, 17097562.
44. Bolisetty MT, Dy G, Tam W, Beemon KL. Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol 2009, 83:12009-12017. 10.1128/JVI.01182-09, 2786729, 19759154.
45. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, Reinberg D. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev 2010, 24:368-380. 10.1101/gad.1886410, 2816736, 20123894.
46. Singh R, Cadeddu RP, Frobel J, Wilk CM, Bruns I, Zerbini LF, Prenzel T, Hartwig S, Brunnert D, Schroeder T, Lehr S, Haas R, Czibere A. The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway. Apoptosis 2011, 16:889-901. 10.1007/s10495-011-0624-y, 21739277.
47. Murohashi I, Yoshida K, Handa A, Murayoshi M, Yoshida S, Jinnai I, Bessho M, Hirashima K. Differential regulation by hematopoietic growth factors of apoptosis and mitosis in acute myeloblastic leukemia cells. Exp Hematol 1997, 25:1042-1050.
48. Gilby DC, Sung HY, Winship PR, Goodeve AC, Reilly JT, Kiss-Toth E. Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia. Immunol Lett 2010, 130:115-124. 10.1016/j.imlet.2009.12.007, 20005259.
49. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 2001, 20:1688-1702. 10.1038/sj.onc.1204245, 11313917.
50. Shirato H, Ogawa S, Nakajima K, Inagawa M, Kojima M, Tachibana M, Shinkai Y, Takeuchi T. A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9. J Biol Chem 2009, 284:733-739. 10.1074/jbc.M804994200, 19010785.
51. Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009, 113:396-402.
52. Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, Zhang Z, Elkahloun A, Cao D, Shen C, Wunderlich M, Wang Y, Neilly MB, Jin J, Wei M, Lu J, Valk PJ, Delwel R, Lowenberg B, Le Beau MM, Vardiman J, Mulloy JC, Zeleznik-Le NJ, Liu PP, Zhang J, Chen J. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun 2012, 3:688. 3514459, 22353710.
53. Yu F, Jia X, Du F, Wang J, Wang Y, Ai W, Fan D. microRNA-155 deficiency in bone marrow results in enhanced tumor metastasis. Mol Cancer Res 2013, 11:923-936. 10.1158/1541-7786.MCR-12-0686, 23666369.
54. Zonari E, Pucci F, Saini M, Mazzieri R, Politi LS, Gentner B, Naldini L. A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. Blood 2013, 122:243-252. 10.1182/blood-2012-08-449306, 23487026.
55. Lyng MB, Laenkholm AV, Sokilde R, Gravgaard KH, Litman T, Ditzel HJ. Global microRNA expression profiling of high-risk ER + breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study. PLoS One 2012, 7:e36170. 10.1371/journal.pone.0036170, 3356496, 22623953.
56. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scandino PT, Sander C, Sawyers CL, Gerald WL. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010, 18:11-22. 10.1016/j.ccr.2010.05.026, 3198787, 20579941.
57. Antonov AV, Knight RA, Melino G, Barlev NA, Tsvetkov PO. MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets. Cell Death Differ 2013, 20:367. 10.1038/cdd.2012.137, 3554342, 23175189.
58. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 2011, 18:1139-1146. 10.1038/nsmb.2115, 3190056, 21909094.
59. Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010, 11:R90. 10.1186/gb-2010-11-8-r90, 2945792, 20799968.
60. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008, 36:D149-D153. 2238905, 18158296.
61. Griffiths-Jones S, Saini HK, Van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158. 10.1093/nar/gkn221, 2238936, 17991681.
62. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
63. Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, Sun S. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 2012, 56:1631-1640. 10.1002/hep.25849, 22610915.
64. Bertani A, Polentarutti N, Sica A, Rambaldi A, Mantovani A, Colotta F. Expression of c-jun protooncogene in human myelomonocytic cells. Blood 1989, 74:1811-1816.
65. Dabrowska MJ, Dybkaer K, Johnsen HE, Wang B, Wabl M, Pedersen FS. Loss of MicroRNA targets in the 3′ untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1. J Virol 2009, 83:8051-8061. 10.1128/JVI.00427-09, 2715787, 19474094.
66. Bueno MJ, Gomez de Cedron M, Gomez-Lopez G, Perez de Castro I, Di Lisio L, Montes-Moreno S, Martinez N, Guerrero M, Sanchez-Martinez R, Santos J, Santos J, Pisano DG, Piris MA, Fernandez-Piqueras J, Malumbres M. Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway. Blood 2011, 117:6255-6266. 10.1182/blood-2010-10-315432, 21478429.